Related references
Note: Only part of the references are listed.Pro12Ala Polymorphism in the PPARG Gene Contributes to the Development of Diabetic Nephropathy in Chinese Type 2 Diabetic Patients
Limei Liu et al.
DIABETES CARE (2010)
Role of PPAR gamma in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential
Jichun Yang et al.
CLINICAL SCIENCE (2009)
Impact of the PPAR-γ2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT
Salvatore De Cosmo et al.
DIABETES (2009)
The human peroxisome proliferator-activated receptor γ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes
ML Caramori et al.
DIABETES (2003)
Peroxisome proliferator-activated receptor-γ2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes -: The Berlin Diabetes Mellitus (BeDiaM) Study
SM Herrmann et al.
DIABETES (2002)
Share Paper
